insights_auto
Why is AGIO down 4.03%?
Dive Deeperchevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$27.60
arrow_downward
-4.03%(-1.16) 1D
US$27.60
0.00% (0.00)
bedtimeAfter hours
Closed: ኖቬም 20, 4:00:00 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
US$28.01
High
US$29.14
Low
US$27.43
Mkt. cap
1.65 ቢ
Avg. vol.
1.13 ሚ
Volume
776.20 ሺ
52-wk high
US$44.07
52-wk low
US$23.02
EPS
-US$6.32
Beta
0.66
Shares outstanding
59.81 ሚ
No. of employees
540
Open
US$28.01
High
US$29.14
Low
US$27.43
Mkt. cap
1.65 ቢ
Avg. vol.
1.13 ሚ
Volume
776.20 ሺ
52-wk high
US$44.07
52-wk low
US$23.02
EPS
-US$6.32
Beta
0.66
Shares outstanding
59.81 ሚ
No. of employees
540
News stories
From web sources and news partners
AP News
·
ከ2 ሰዓቶች በፊት
S&P 500 sinks 3.7% and Nasdaq composite goes negative for the year as tech sell-off worsens
The Motley Fool
·
ከ1 ሰዓት በፊት
Report: Goldman Sachs Predicts the S&P 500 Will Gain 26% in 12 Months
WSJ
·
ከ16 ሰዓቶች በፊት
S&P 500 Flirts With Correction
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc